Podcasts about Transfusion medicine

In this episode, you'll hear a conversation with transfusion medicine expert Michelle Mullens about how blood donation underpins patient health and the critical role it plays in healthcare. Discover how donated blood is vital not only for trauma care, but also for cancer treatments, chronic illnesses like sickle cell disease, and a wide range of surgeries. The discussion explores the growing challenges of blood supply shortages, the importance of specialized blood types, and how automation in blood banks is helping labs maintain safety and efficiency despite staffing pressures. Learn how each donation makes a difference and why maintaining a robust blood supply is essential for patient care and safety.   About our speaker:  Michelle Mullens Global Portfolio Marketing Manager for Transfusion Medicine, QuidelOrtho Before beginning her career on the vendor side with QuidelOrtho, Michelle was a senior medical technologist at Baptist Health, serving in leadership roles in transfusion medicine and immunohematology for nearly 30 years. With QuidelOrtho, Michelle has served as a technical specialist, business development consultant and clinical science liaison before taking on her current role.

In part two of the How I Treat Series on Transfusion Medicine Dr. Erica Wood interviews the "How I Manage Major Hemorrhage" author group: Drs. Jeannie Callium, Keyvan Karkouti, and Ron George.Find the full published review series in Volume 145 Issue 20 of Blood Journal.

Dr. Zach Deutch interviews Dr. Nicole Guinn, guest editor of the June ASA Monitor, and Dr. Steven Frank, contributor, about blood management and transfusion medicine. Listen in as the guests share thoughts on bloodless care, the history of transfusion medicine, patient populations, the possibilities of predictive modeling, and more. Recorded April 2025.

In this two-part series, Dr. Erica Wood talks with Drs. Masja de Haas, Helen Savoia, and Stella Chou about their articles in the How I Treat Series on Transfusion Medicine. Topics include noninvasive prenatal testing for red blood cell and platelet antigens, transfusion cases in sickle cell disease, and pregnant patients who are alloimmunized to RBC antigens. Find the full published review series in Volume 145 Issue 20 of Blood Journal.

In this insightful episode of The Pre-Hospital Paradigm Podcast, Dr. John Hill and co-host Scott Wildenheim dive deep into the evolving world of blood transfusion medicine with special guests Vicki Cary, Manager of Transfusion Medicine, and Matt Howlett, System QA Coordinator for Blood Banks. Together, they explore the critical role of blood and blood products in EMS and trauma care, the challenges of maintaining blood supplies, and recent advancements expanding paramedic scope of practice in Ohio. #prehospitalparadigmpodcast

As Dr. Hill, Scott, Vicky and Matt start to wind up the discussion regarding transfusion medicine for EMS, i.e. using blood products in the prehospital setting, they discuss the proper storage requirements necessary for products and the costs of maintaining the blood collection, storage and distribution process. What's being considered before implementing blood products into the streets.

Scott and Dr. John Hill continue with their guests from the UH blood bank. The discussion continues regarding the emergent useage of blood products before and after the type and screening which can be done with 10 minutes or less depending on the type of testing equipment. They also move on to educating EMS professionals regarding being a part of the collection/donation process.

This month, the crew gets together with, Victoria Cary and Matt Howlett, members of the UH system's blood bank to talk about the progress of transfusion medicine becoming within the practice scope of EMS.  The information is based on rules, regulations and laws of the state of Ohio.  In Part 1, the crew and guests reviews the A, B, Os basics of “blood science.”

Send us a textDr. Tina Ipe, MD, MPH is Chief Executive Officer at Regen Med Clinic ( https://www.regenmed.vip/ ), a medical practice which provides multi-specialty infusions, cutting-edge treatments such as therapeutic apheresis (plasmapheresis and collections), as well as novel aesthetic treatments, for patients with a variety chronic illnesses. Dr. Ipe is a board-certified physician and clinical researcher. Before entering private practice, she was Chief Medical Officer at the Oklahoma Blood Institute, Associate Medical Director at Houston Methodist Hospital, and  Division Director at University of Arkansas for Medical Sciences (UAMS). She is an expert in the fields of blood disorders, immunology, therapeutic apheresis, blood banking, and transfusion medicine. She has published more than 50 peer-reviewed manuscripts and book chapters.Dr. Ipe received her medical degree from the Medical College of Virginia and completed her residency in clinical pathology and fellowship in transfusion medicine at the Hospital of the University of Pennsylvania. She also has an MPH from Dartmouth.#TinaIpe #BloodDisorders #Blood #Biotherapies #Immunology #TherapeuticApheresis #BloodBanking #TransfusionMedicine #RegenerativeMedicine #TherapeuticPlasmaExchange #ConvalescentPlasma #ExtracorporealPhotopheresis #Parabiosis #Longevity #Aging #HospiceCare #STEM #Innovation #Science #Technology #Research #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcastSupport the show

Let me ask you this. Who does the blood transfusions in your practice? The vets? Or the nurses?  Yes, it will be us monitoring the patient and collecting the vitals, but who… Calculates the blood? Prepares it? Performs the donations? Cares for the donors? If it's not the nurses, I'm going to suggest it should be - because there's no reason for us not to do all of these things (as long as we run our plan past the vets and ensure they agree before going ahead!) In this episode of the Medical Nursing Podcast we're taking the confusion out of transfusions, so you can confidently care for your haematology patients in practice. ---

In this episode of Critical Matters, Dr. Zanotti discusses the use of intravenous albumin in critical care. He is joined by D. Jeannie Callum, Director of Transfusion Medicine and Professor of Pathology and Molecular Medicine at Queens University in Ontario, Canada. Dr. Callum's research focuses on blood utilization, hemostasis in the bleeding patient, and transfusion-related errors. She has received numerous awards and published extensively. Dr. Callum is the lead author of “Use of Intravenous Albumin: A Guidelines from the International Collaboration for Transfusion Medicine Guidelines,” published earlier this year in CHEST. Additional Resources: Use of Intravenous Albumin. A Guideline from the International Collaboration for Transfusion Medicine Guidelines. CHEST 2024: https://journal.chestnet.org/article/S0012-3692(24)00285-X/fulltext International Collaboration for Transfusion Medicine Guidelines Website: https://www.ictmg.org/ Ten myths about albumin. M Joannidis, et al. Intensive Care Med 2022: https://pubmed.ncbi.nlm.nih.gov/35247060/ A comparison of albumin and saline for fluid resuscitation in the intensive care unit. SAFE Study Investigators. N Engl J Med 2004: https://pubmed.ncbi.nlm.nih.gov/15163774/ Albumin Replacement in Patients with Severe Sepsis or Septic Shock. ALBIOS Study Investigators. N Engl J .Med 2014: https://www.nejm.org/doi/full/10.1056/NEJMoa1305727 Books mentioned in this episode: Ending Medical Reversal: Improving Outcomes, Saving Lives. By Vinayak K. Prasad: https://bit.ly/4dAimRa The Time Machine. By H.G. Wells: https://amzn.to/4eK4apG

We'd love to hear from you! Send us a text message.In this episode of Discover Daily, we begin with Meta's Orion AR glasses prototype, which uses silicon carbide lenses and a neural wristband for intuitive control. These lightweight glasses project holograms onto the real world, offering a 70-degree field of view and gesture controls. While still in development, Orion represents a significant step towards Meta's vision of AR as the future of personal computing.We also delve into OpenAI's controversial shift from a nonprofit to a for-profit model, potentially valuing the company at $150 billion. This move has sparked debates about AI ethics and development priorities, with critics like Elon Musk calling it "illegal." The restructuring aims to attract investors and compete with tech giants, but raises questions about OpenAI's commitment to its original mission of developing beneficial AI.Our deep dive focuses on the discovery of the MAL blood group system, solving a 50-year mystery in hematology. This rare blood type, characterized by the absence of the AnWj antigen, has significant implications for transfusion medicine and patient care. The discovery opens new avenues for research in genetic screening, antigen development, and personalized medicine, potentially leading to improved transfusion safety and novel therapeutic approaches.Perplexity is the fastest and most powerful way to search the web. Perplexity crawls the web and curates the most relevant and up-to-date sources (from academic papers to Reddit threads) to create the perfect response to any question or topic you're interested in. Take the world's knowledge with you anywhere. Available on iOS and Android Join our growing Discord community for the latest updates and exclusive content. Follow us on: Instagram Threads X (Twitter) YouTube Linkedin

Send us a textDr. Deborah Sesok-Pizzini, MD, MBA, is Chief Medical Officer And Senior Vice President, Labcorp Diagnostics, and Global Head of Quality And Discipline Director, Immunohematology, Labcorp ( https://www.labcorp.com/deborah-sesok-pizzini-md-mba ), where she is involved in furthering the company's initiatives to enhance the patient experience, enable health provider decisions and develop innovative testing solutions.Dr. Sesok-Pizzini joined Labcorp with over two decades of experience in healthcare, holding multiple appointments with The Children's Hospital of Philadelphia, including Patient Safety Officer, Chief of the Division of Transfusion Medicine and Vice-Chief of Pathology and Laboratory Medicine. She was also a professor of clinical pathology and laboratory medicine at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, PA.Dr. Sesok-Pizzini earned her medical degree from the Penn State College of Medicine and did her residency and fellowship at The University of Pennsylvania's Perelman School of Medicine. She also graduated from Villanova University, with a Master of Business Administration degree with a concentration in finance.Dr. Sesok-Pizzini holds certifications in clinical pathology and blood bank and transfusion medicine. She is a member of the College of American Pathology, the American Society of Clinical Pathology, and the Association for the Advancement of Blood and Biotherapies. She is a board member of the Intersociety Council for Pathology Information and serves as an adjunct professor with the University of Pennsylvania's Perelman School of Medicine.#DeborahSesokPizzini #ChiefMedicalOfficer #Labcorp #Diagnostics #Immunohematology #ChildrensHospitalOfPhiladelphia #CHOP  #TransfusionMedicine #Pathology #LaboratoryMedicine #PerelmanSchoolOfMedicine #UniversityOfPennsylvania #Penn #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the Show.

The New Zealand Blood Service is calling out for desperately needed plasma.   The demand for so called 'liquid gold' grows by 10 percent each year, with supply not keeping up.  Based on the demand, they'll need at least 150 more people to start donating regularly.  Transfusion Medicine Specialist Richard Charlewood told Francesca Rudkin the problem is that they're reliant on other countries.  He said that it's an American export business, and so when there's a drop in donations—like there was during Covid— it's an America-first policy, so we're at risk by not being self-sufficient.  LISTEN ABOVE See omnystudio.com/listener for privacy information.

5 Questions is a new series of Blood, Sweat and Smears, hosted by our Senior Director, Bjorn Stromsness who asks 5 questions to physicians in and around the disease areas we work in. In this episode, we are joined by Dr. Patricia Kopko, a Professor of Pathology at UC San Diego, Director of Transfusion Medicine, and Associate Director of the Immunogenetic and Transportation Laboratory.  

Descubra neste episódio as doenças mais comuns que afetam cães e gatos durante o inverno, com destaque para os sinais de alerta e as opções de tratamento disponíveis para cada uma delas. Estratégias para mitigar os efeitos do clima frio e orientações essenciais aos tutores também fazem parte das informações cedidas pela colaboradora do Vetsapiens, Dra. Karin Botteon. Dra. Karin Botteon Graduada pela Universidade Estadual de Londrina Residência em Clínica Médica de Pequenos Animais pela UNESP Campus Botucatu Mestrado pela Universidade de São Paulo Depto. de Cirurgia e Anestesiologia Enfoque em Medicina transfusional e banco de sangue de cães e gatos Gerente Técnica Pets da Boehringer Ingelheim Animal Health Membro Association of Veterinary Hematology and Transfusion Medicine, Associação Brasileira Veterinária de Hematologia e Medicina Transfusional e International Society of Feline Medicine.   Conecte-se com o Vetsapiens! www.vetsapiens.com https://www.facebook.com/vetsapiens https://www.instagram.com/vetsapiens/

Host Arlene Connor and guest Helen Rooney discuss the crucial role of vet nurses in delivering safe and effective blood transfusions. Helen shares insights and recommendations for ensuring safe transfusions, including compatibility testing, proper product handling, storage of blood products, and careful delivery techniques.Vet nurses play a key part in monitoring patients undergoing transfusions. Helen highlights the importance of vigilance post-transfusion, as delayed reactions can occur 24 hours or even days later.Powered by IVC EvidensiaAt IVC Evidensia we're building the world's best veterinary group, with a single purpose; healthy animals and happy owners.Visit ivcevidensia.co.uk to find out more, or follow us on social media.Please note that the views expressed by hosts and guests in this podcast Clinic do not necessarily reflect those of IVC Evidensia.Links:Pet Blood Bank UK website for guidance and step-by-step advice documents: https://www.petbloodbankuk.org/vet-professionals/i-need-advice/NCert in Transfusion Medicine: https://improveinternational.com/uk/coursedate/ncert-vppcert-transfusion-medicine-online/

Host: Darryl S. Chutka. M.D. [@chutkaMD] Guest: Justin E. Juskewitch, M.D., Ph.D. January is National Blood Donor Month | Here are a few interesting facts regarding blood donations: Over 4.5 million American lives are saved each year by blood transfusion and approximately 40,000 units of donated blood are used each day in the U.S.  A single individual involved in a motor vehicle accident can easily require over 100 units of blood.  We each have about 10 units of blood in our body and each donation represents about one unit. Surprisingly, only 38% of the population is eligible to donate blood and of these eligible individuals, only 5%, actually donate. The topic for this podcast is “Blood Donation and How it Relates to Primary Care” and my guest is Justin E. Juskewitch, M.D., Ph.D., from Transfusion Medicine at the Mayo Clinic. Connect with the Mayo Clinic's School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., speaks with Timothy Wiltshire, Ph.D., assistant professor of laboratory medicine and pathology in the Division of Transfusion Medicine, to discuss what's new with CAR-T cells. Timestamps:0:00 Introduction0:49 Why is CAR-T important for healthcare folks to appreciate in 2023?3:05 What should healthcare professionals understand about CAR-T?4:55 Is it true to say that we've seen success specifically in the hematologic cancers like leukemias, but not necessarily like the solid tumors, like breast cancer or prostate cancer?7:27 Are there a few things that you look for when you read an article that's reporting about CAR-T cells?10:24 Can you explain what off-target effects are? 11:46 What are some of the new things that have come out recently?13:24 What's involved with creating your typical CAR-T?14:58 What are your thoughts on the future for the field?16:22 Is this a more equitable product or are there still some struggles with getting equity for different populations with CAR-T?17:25 Is the promise of an off-the-shelf not just for an emergency, but could that be a cheaper option?18:00 Outro  

Dr. David Roh is an Assistant Professor of Neurology at Columbia University where he is an attending neurointensivist. In this lecture, Dr. Roh reviews the currently implemented diagnostic and treatment approaches for hemorrhage control in intracerebral hemorrhage and discusses novel approaches being investigated.

Platelet refractoriness can be life threatening for thrombocytopenic patients. Penn State Health pathologist Melissa George, DO, FCAP, and pediatrician Sarah Kesterson, MD, authored the new Clinical Pathology Improvement Program course on this topic. In this CAPcast, they discuss how narrowing the differential diagnosis for poor platelet transfusion response is critical to guide appropriate management and product selection. To purchase this case, please visit the CAP's estore: https://estore.cap.org/OA_HTML/xxCAPibeCCtpItmDspRte.jsp?section=10139&item=848356&sitex=10020:22372:US

Major hemorrhage is life-threatening and can occur in a variety of clinical settings. A review paper in CMAJ, entitled "Nonsurgical management of major hemorrhage," advocates for the implementation of massive hemorrhage protocols across all types of hospitals to optimize patient care.Dr. Jeannie Callum, the article's lead author and the Director of Transfusion Medicine at Kingston's Health Sciences Centre speaks with Drs. Blair Bigham and Mojola Omole about her work standardizing massive hemorrhage protocols throughout Ontario. Dr. Callum shares the transformative moment that inspired her to develop a province-wide protocol, starting from the point of roadside patient care.She then details the critical need for precision in managing major hemorrhage, emphasizing a rapid response within the "golden hour." Dr. Callum outlines key components of care such as swift administration of tranexamic acid and the detection of coagulopathy. She then simplifies the main elements of a massive hemorrhage protocol into what she calls "the seven 'T's."In rural settings, Dr. Callum identifies the need for a simplified protocol due to constraints like smaller medical teams and a lack of comprehensive laboratory tests. Despite these challenges, she recommends innovative solutions like the immediate administration of tranexamic acid and encourages physicians to educate themselves about novel point-of-care testing technologies such as viscoelastic testing.Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.You can find Blair and Mojola on Twitter @BlairBigham and @DrmojolaomoleTwitter (in English): @CMAJ Twitter (en français): @JAMC FacebookInstagram: @CMAJ.ca The CMAJ Podcast is produced by PodCraft Productions

How does Military Medicine learn lessons and overcome barriers in trauma resuscitation? How have transfusion practices on the battlefield evolved? Tune in and find out!    Intro:  WarDocs had the pleasure of discussing the evolution of transfusion medicine on the battlefield with LTC(R) Philip C. Spinella, MD, a Professor in the Departments of Surgery and Critical Care Medicine and Co-director of the Trauma and Transfusion Medicine Research Center at the University of Pittsburgh. We delved into the history of blood transfusion practices during the Vietnam War, the shift from using whole blood to a mixture of red cells and crystalloids, and the lessons learned from Iraq and Afghanistan. We also explored the concept of damage control resuscitation, the transition from component therapy to whole blood therapy, and the barriers faced in developing high-level evidence through randomized controlled trials. Additionally, we touched on life-threatening hemorrhage in pediatric patients, the differences between adult and pediatric populations, and the future of therapy for life-threatening hemorrhage. Don't miss this fascinating episode highlighting the importance of having various tools in the "toolbox" to ensure the best care for patients experiencing life-threatening hemorrhage.   Chapters: (0:00:00) - Transfusion Medicine on Battlefield (0:09:12) - The Evolution of Hemostatic Resuscitation (0:18:24) - Damage Control Resuscitation (0:28:10) - Trauma Care (0:37:08) - Precision Transfusion Medicine   Chapter Summaries: (0:00:00) - Transfusion Medicine on Battlefield (9 Minutes) In this episode, we explore the evolution of transfusion medicine on the battlefield with LTC(R) Philip C. Spinella, MD, a Professor in the Departments of Surgery and Critical Care Medicine and Co-director of the Trauma and Transfusion Medicine Research Center at the University of Pittsburgh. We discuss how strategies for hemostatic resuscitation have moved from component therapy to whole blood transfusion. Dr. Spinella shares his experiences deploying to Baghdad in 2004 and working with the 31st Combat Support Hospital. (0:09:12) - The Evolution of Hemostatic Resuscitation (9 Minutes) We dive into the history of blood transfusion practices during the Vietnam War and the shift from using whole blood to a mixture of red cells and crystalloids. The conversation highlights the lessons learned from Iraq and Afghanistan and the importance of keeping this knowledge alive for future conflicts. The discussion also covers the role of transfusion ratios in improving outcomes, the origin of the one-to-one-to-one ratio, and the use of recombinant activated factor VIIa in trauma resuscitation. Dr. Philip C Spinella shares the fascinating story behind these developments and the importance of considering a bundle of care for optimal patient outcomes. (0:18:24) - Damage Control Resuscitation (10 Minutes) We discuss the concept of damage control resuscitation and the transition from component therapy to whole blood therapy with the various barriers that needed to be overcome. Focusing on the importance of safety in transfusion medicine, we explore the challenges in developing high-level evidence through randomized controlled trials and the alternative approach of focused empiricism. We also examine the three main barriers to whole blood use in hemostatic resuscitation: ABO specificity, leukocyte reduction, and cold storage platelets. (0:28:10) - Trauma Care (9 Minutes) In this conversation, we examine life-threatening hemorrhages in pediatric patients and the differences between adult and pediatric populations. We discuss an NIH-sponsored prospective observational study that found a higher mortality rate in children with massive bleeding compared to adults. We also explore the types of whole blood, their nuances, and how they differ from component therapy. Additionally, we touch on the role of freeze-dried plasma in transfusion options and the current state of synthetic blood products. Ultimately, we emphasize the importance of having various tools in the "toolbox" to ensure the best care for patients experiencing life-threatening hemorrhage. (0:37:08) - Precision Transfusion Medicine (9 Minutes) We delve into the development of a dry artificial whole-blood product and its potential applications for various types of bleeding. This project, funded by DARPA, aims to create custom-made whole blood-like products specific to a patient's coagulopathy. We also discuss the challenges and barriers in conducting clinical trials in transfusion medicine, emphasizing the importance of funding, access to blood products, and the need for precision transfusion medicine. The conversation also touches on the future of therapy for life-threatening hemorrhage, focusing on metabolism-reducing agents to salvage patients in shock. Episode Keywords: Transfusion Medicine, Battlefield, Hemostatic Resuscitation, Whole Blood Therapy, Component Therapy, Damage Control Resuscitation, Vietnam War, Iraq and Afghanistan, Trauma Care, Life-Threatening Hemorrhage, Pediatric Patients, Blood Transfusion Practices, ABO Specificity, Leukocyte Reduction, Cold Storage Platelets, Freeze-Dried Plasma, Synthetic Blood Products, Precision Transfusion Medicine, Coagulopathy, Metabolism-Reducing Agents   #wardocs #military #medicine #podcast #TransfusionMedicine #BattlefieldMedicine #HemostaticResuscitation #WholeBloodTherapy #DamageControlResuscitation #PediatricHemorrhage #TransfusionResearch #MilitaryMedicine #BloodTransfusionEvolution #LifeSavingMedicine   Honoring the Legacy and Preserving the History of Military Medicine The WarDocs Mission is to improve military and civilian healthcare and foster patriotism by honoring the legacy, preserving the oral history, and showcasing military medicine career opportunities, experiences, and achievements. Find out more and join Team WarDocs at https://www.wardocspodcast.com/ Check our list of previous guest episodes at https://www.wardocspodcast.com/episodes  Listen to the “What We Are For” Episode 47. https://bit.ly/3r87Afm WarDocs- The Military Medicine Podcast is a Non-Profit, Tax-exempt-501(c)(3) Veteran Run Organization run by volunteers. All donations are tax-deductible and go to honoring and preserving the history, experiences, successes, and lessons learned in military medicine. A tax receipt will be sent to you. WARDOCS documents the experiences, contributions, and innovations of all military medicine Services, ranks, and Corps who are affectionately called "Docs" as a sign of respect, trust, and confidence on and off the battlefield, demonstrating dedication to the medical care of fellow comrades in arms.           Follow Us on Social Media Twitter: @wardocspodcast Facebook: WarDocs Podcast Instagram: @wardocspodcast LinkedIn: WarDocs-The Military Medicine Podcast

We are taking a small pause from our breast cancer series to discuss an important topic that is so critical to understand for clinical practice, no matter what discipline of medicine you are in: the fundamentals of transfusion medicine. This topic often shows up quite frequently on board exams, as well. In this episode, we talk about terms such as “type and screen” and more. Content: - What is a "type and screen"?- What does this process entail? - What is the difference between this and crossmatching? - When do we see discrepancies in the antibody screen? ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodesLove what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Google Podcast

This week's episode is part 2 of our series focusing on transfusion medicine. We discuss indications for pre-transfusion protocols, as well as infectious and non-infectious, and acute & delayed risks of transfusions

This week's episode is part 1 of a 2 part series focusing on transfusion medicine. In part 1, we cover important details on blood group systems, blood components, indications for these components, and quickly cover apharesis. 

Continuing education episode! Advances in the practice of Transfusion Medicine happen regularly, and it can be difficult for both learners and those with more experience to keep up with the latest information. Further, many learners (and more “seasoned” types!) lack experience to evaluate strengths and weaknesses of the evidence in the medical literature. Dr. Rich Haspel joins me to describe how to evaluate evidence in the medical literature, and to discuss his take on low-titer group O whole blood.

Alexis (Lexi) Hansen Bs, LVT, RVT, VTS (ECC) started her career in the veterinary industry at Morrisville State College where she received her Bachelors in Equine Sports Medicine and Rehabilitation. She then went on to attend SUNY Delhi to obtain her Associates in Veterinary Technology. After becoming an LVT in New York in 2016, she moved to Charlotte, North Carolina and obtained her RVT while pursuing her dream of working in emergency medicine. In 2020 she relocated to the Raleigh-Durham area to join the emergency and critical care department at BluePearl in Cary, NC. Working alongside three criticalists she was able to obtain her VTS(ECC) in 2021. Over the last year she has transitioned into a leadership role as the emergency and critical care technician manager. She works closely with their in-house technician trainer to ensure her and her team are always practicing the best standard of medicine. When she is not busy at work, she is spending time with boyfriend, two pit bulls, baking, or gardening. 

CE episode! To celebrate the 100th episode of Blood Bank Guy Essentials, Dr. Chaffin invites multiple previous guests (plus one brand new one!) to share brief "Pearls of Wisdom" with you. Learners of every level are sure to find Transfusion Medicine tips and tools to help care for patients in better ways. Thanks to all who have listened to this podcast in the past 7 years!

Today my guests are Lori Harada and Carly Newton from Terumo Blood and Cell Technologies What we discuss with Lori and Carly: Their backgrounds in nursing How they joined Terumo BCT Therapeutic plasma exchange and red blood exchange, and some conditions where this is used How these technologies benefit patients Some exciting advancements coming in transfusion medicine Links for this episode: Pathology 101 For Tissue Image Analysis Health Podcast Network  LabVine Learning The ConfLab from LabVine Dress A Med scrubs   Terumo BCT World Apheresis Association American Society for Apheresis American Society for Hematology   People of Pathology Podcast: Twitter Instagram

Dr. Justin Kreuter, Transfusion Medicine attending at Mayo Clinic, joins Alex and Venk on the podcast to talk about transfusion in its many dimensions. We talk through a model of evaluation for patients with life threatening bleeding, how to interpret tests, the science behind the 1:1:1 ratio of trauma transfusion practice and much much more! CONTACTS Twitter - @AlwaysOnEM; @VenkBellamkonda; @KreuterMD Instagram – @AlwaysOnEM; @Venk_like_vancomycin; @ASFinch; @KreuterMD Email - AlwaysOnEM@gmail.com REFERENCES & LINKS Lab medicine rounds podcast link: https://news.mayocliniclabs.com/homepage/podcasts-2/lab-medicine-rounds/ Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, plaeteles, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma – the PROPPR Randomized Clinical Trial. JAMA. 2015; 313(5):471-482 Holcomb JB, Del Junco DJ, Fox EE, et al. The prospective observational multicenter major trauma transfusion (PROMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg. 2013 Feb;148(2):127-136 J-Y Borg et al. FEIBA in the treatment of acquired hemophilia A: results from the prospective multicentre French ‘FEIBA dans l'hemophilie A acquise' (FEIBHAC) registry. Haemophilia. 2015 May;21(3):330-337 Sharp G, Young CJ. Point of care viscoelastic assay devices (rotational thromboelastometry and thromboelastography): a primer or surgeons. Anz J Surg. 2019 Apr;89(4):291-295 Hospital Liaison Committee for Jehovah's Witnesses: https://www.jw.org/en/medical-library/strategies-downloads/hospital-liaison-committees-jehovahs-witnesses/

Well Said has brought on Dr. Linda Shore-Lesserson, Professor of Anesthesiology at the Zucker SOM and the Director of Cardiovascular Anesthesiology at Northwell and Dr. Sherry Shariatmadar, Associate Professor of Pathology at the Zucker SOM and Director of Transfusion Medicine and Apheresis Services at NSUH. Our guests will be talking about the advantages and impact of minimizing the use of blood transfusions and conserving the patient's own blood.

The fascinating history of the discovery of blood groups goes back to 1900 with the breakthrough that came when Dr. Karl Landsteiner, an Austrian scientist, discovered three human blood groups. These were the A, B, and O blood groups. Two students who worked with Karl Landsteiner discovered the fourth human blood group, the AB. These two were A. van Decastello and A. Sturli. These four blood groups together are what we today know as the ABO blood group system. In this podcast episode with Dr. Jill Storry, you will learn the fascinating journey behind discovering blood groups and stay up to date on the latest blood groups that have been discovered.  About the Speaker:  Jill Storry, PhD, Lund University, Sweden  Dr. Jill Storry is a professor at the Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, and is responsible for the immunohematology laboratories in the Department of Clinical Immunology and Transfusion Medicine. She is an American Association of Blood Banking (AABB) National Blood Foundation Scholar for her discovery of the genetic basis of the Vel blood group system. Her awards include the British Blood Transfusion Society's Margaret Kenwright and Race & Sanger awards, the AABB's Sally Frank Award, and an ISBT award for outstanding contributions to education. Dr. Storry has authored more than 60 original papers, reviews, and textbooks, and spoken at more than 100 international and national conferences and courses. She is a member of the editorial board of Transfusion Medicine Reviews, Transfusion and Immunohematology, and section editor for Vox Sanguinis.

A High Court judge has ruled in favour of health authorities who sought court guardianship of a gravely ill baby boy after his parents refused a blood transfusion unless they got blood from unvaccinated donors. Justice Ian Gault ordered the baby to be placed under the guardianship of the court until the surgery and post-operative recovery were completed, with the guardianship lasting until January 31st 2023 at the latest. Otago University transfusion medicine specialist Jim Faed says the judge would have weighed the decision on the principle of putting the child's interests first. "Even though the parents have got very real interest in the child's future, the decision would have been made that the immediate concern is a health problem. And therefore, the judge would have decided on that basis." LISTEN ABOVESee omnystudio.com/listener for privacy information.

Join Yvonne Brandenburg, RVT, VTS SAIM and Jordan Porter RVT, VTS SAIM as we talk about: Its Thanksgiving Time! We chit chat a bit and then throwback to one of our very first episodes from 3 years ago! Can you believe it has been 3 years?! None other than Pancreatitis, because tis the season!     Resources We Mentioned in the Show  When Rare Isn't a Strong Enough Word:  https://news.cvm.ncsu.edu/when-rare-isnt-a-strong-enough-word/ ·        Texas A&M GI Lab: o   http://www.cvm.tamu.edu/gilab/research/pancreatitis-information     Merck Veterinary Manual: ohttps://www.merckvetmanual.com/digestive-system/the-exocrine-pancreas/pancreatitis-in-small-animals ohttps://www.merckvetmanual.com/digestive-system/the-exocrine-pancreas/overview-of-the-exocrine-pancreas   ·       IMFPP Anatomy: o   https://www.internalmedicineforpetparents.com/endocrine.html   CE for using Plasma in Pancreatitis patients: ohttps://vetgirlontherun.com/treating-the-pancreatitis-patient-with-plasma-vetgirl-veterinary-continuing-education-blog-scheduled/   Transfusion Medicine: https://imfpp.org/jordanstransfusionarticle  https://imfpp.org/transfusionbook  Quality of Life Tracker https://imfpp.org/QOLscale      Thanks so much for tuning in. Join us again next week for another episode!  Want to earn some RACE approved CE credits for listening to the podcast? You can earn between 0.5-1.0  hour of RACE approved CE credit for each podcast episode you listen to.    Join the Internal Medicine For Vet Techs Membership to earn and keep track of your continuing education hours as you get your learn on!   Join now! http://internalmedicineforvettechsmembership.com/   Get Access to the Membership Site for your RACE approved CE certificates Sign up at https://internalmedicineforvettechsmembership.com  Get Access to the Technician Treasure Trove  Sign up at https://imfpp.org/treasuretrove    Thanks for listening!  – Yvonne and Jordan   

Dr. Marques received her M.D. from the Federal University of Rio Grande do Sul in Brazil and trained in Internal Medicine at the same institution. She and her husband moved to the United States in 1986.  She spent 2 years at NIH and 5 years at Harvard Medical School as a research fellow before coming to UAB to train in Pathology.  She has been a faculty member since 1998 in the Laboratory Medicine sections of Apheresis, Coagulation and Transfusion Medicine.  She has been very active in national societies having been an ASFA Board member for 8 years and President from 2014-2015, as well as President of the Academy of Clinical Laboratory Physicians and Scientists (ACLPS) from 2016-2017.  She loves to share her experiences, joys and setbacks with others, always focusing on what can be learned and applied in the future. Faculty Profile:  https://scholars.uab.edu/display/henrique

High-prevalence antigens occur in greater than 99% of the population. Antibodies to high-prevalence antigens are rare and may be difficult to identify due to the lack of antigen-negative panel cells for these antigens. Examples of antibodies to high-prevalence antigens are: anti-k, anti-Kpb, anti-Jsb, and anti-Lub among many others There is a need to proper identify these antibodies before transfusion to differentiate clinically significant antibodies, that could cause hemolytic transfusion reactions or hemolytic disease of the fetus and newborn from those with little or no clinical relevance. Their specific identification is often difficult, labor-intensive, and time-consuming and it may be difficult to find antigen-negative compatible blood for the patient in need of a transfusion Learn in this episode clues to recognize if an antibody to a high-prevalence antigen is present and how to apply practices for their identification in the lab and additional recommendations for patient management.   About Our Speaker:  Shane Grimsley, DipRCPath; holds a diplomate in Pathology from the Royal College of Pathologists, UK and has been working at the International Blood Group Reference Laboratory, NHSBT in the UK since 2009, as laboratory manager from 2015 and Senior Clinical Scientist since 2020. Since 2017, Shane has been the lead scientific advisor to the UK NEQAS Red Cell Genotyping scientific advisory group, compiling complex reports to help educate the users. He has been an active member of the editorial board for Immunohematology as well as a reviewer for Vox Sanguinis and Transfusion Medicine since 2019. Shane is the winner of the 2020 Race and Sanger award from the British Blood Transfusion Society for outstanding contribution to the field of Transfusion, primarily for his work developing a genotyping platform for accurate prediction of variant phenotypes in patients with Sickle Cell Disorder. He also is a winner of the 2010 Margaret Kenwright Young Scientist of the year from the British Blood Transfusion Society, for his work resolving complex compound heterozygous allele combinations and the identifying the associated antibody specificities. Shane is an international scientific speaker and a workshop instructor for immunohematology topics in conference programs, such as ISBT. He also has been involved in the identification of new blood group systems, new antigens and novel alleles.  Shane is helping lead a team of skilled and passionate scientists to resolve the world's most complex immunohematology cases, contributing to ground-breaking projects that have improved the standards of care for patients.  

Continuing education episode! If a research project has been going on for over 30 years, you would think it's probably pretty good, right? Well, that's how long the REDS research project, sponsored by the US National Heart, Lung, and Blood Institute (NHLBI) has been breaking new ground in Transfusion Medicine. The two co-chairs of the fourth phase, REDS-IV-P, are here to explain why the best is yet to come!

In Sickle Cell Disease (SCD) patients, one of the most critical treatments is a blood transfusion. A blood transfusion is used to provide normal red blood cells to the patient's body. Red blood cell transfusions help lessen anemia and reduce the blood's viscosity, allowing it to flow more freely, ease disease symptoms and prevent complications. Alloimmunization is common in patients with SCD and may complicate transfusion therapy. For many patients, a close blood type match is essential and is found in donors of the same race or similar ethnicity. In this episode, learn why patient phenotyping and prophylactic matching to reduce alloimmunization is recommended for SCD patients and why donor source for blood donations of the same race or similar ethnicity is critical.   About the Speaker: Dr. Stella T. Chou is Chief of the Division of Transfusion Medicine, board-certified in Blood Banking and Transfusion Medicine, and an attending physician in the Division of Hematology at Children's Hospital of Philadelphia. Dr. Chou earned her medical degree from New York Medical College in Valhalla, NY. She specializes in caring for children with SCD, those who make antibodies against red blood cell transfusions (alloimmunization), and those requiring apheresis. Her research interests are focused on improving red blood cell matching for patients through the use of innovative tools. Her work has demonstrated that inheritance of variant blood group antigens in patients with SCD contributes to their high rate of red blood cell antibody formation. Her ongoing work focuses on the genetic matching of red blood cells and creating customized induced pluripotent stem cells (iPSCs) with rare blood group antigen combinations as renewable sources of red blood cell reagents to improve antibody identification and donor red blood cell matching. For her innovative research, she is a recipient of the National Blood Foundation Hall of Fame award. Dr. Chou is a worldwide recognized author and speaker with over 100 publications and lectures. In addition to her clinical work, Dr. Chou serves as an Associate Professor of Pediatrics at the Perelman School of Medicine, University of Pennsylvania.

ASCP was the first medical professional organization to elect a woman as president when Dr. Emma Moss earned the title in 1955. And while women continue to make strides in the field of pathology and laboratory medicine, there is still much to be done. So, what can we do to promote gender equality in the laboratory workforce? How can we create more opportunities for women to ascend from the bench to positions of leadership? On this episode of Inside the Lab, our hosts Dr. Lotte Mulder and Ms. Kelly Swails are joined by Dr. Kimberly Sanford, MD, MASCP, MT(ASCP), Medical Director of Transfusion Medicine and Director of Undergraduate Medical Education in the Department of Pathology at Virginia Commonwealth University, Dr. Nidia Messias, MD, Renal Pathologist and Associate Professor of Pathology and Immunology at Washington University School of Medicine in St. Louis, and Ms. Tiffany Channer, MPH, MLS(ASCP)CM, Assistant Administrative Laboratory Director and Quality Manager at a local community hospital in Westchester County, New York, to discuss the contributions of women in pathology and laboratory medicine. Our panelists describe some of the myths surrounding women in pathology and laboratory medicine and explain how to improve work conditions for women in the lab. They share what inspired them to enter the field and how the landscape of laboratory medicine has changed for women and other minority groups since they entered the workforce. Listen in for advice for women entering the field today and learn about the role mentorship plays in helping women rise through the ranks in pathology and laboratory medicine. Topics Covered· Notable contributions women like Dr. Renee Habib, Dr. Sophie Spitz, and Dr. Vivian Pinn have made to the field of pathology and laboratory medicine· Why women need both mentorship and sponsorship to rise through the ranks of the laboratory· Myths surrounding women in pathology and laboratory medicine· How to improve working conditions for women in the laboratory and promote women's empowerment in field of pathology and lab medicine· Our panelists' hopes for the next 100 years in pathology and laboratory medicine · Advice to women entering the field of pathology and laboratory medicine today Connect with ASCPASCPASCP on FacebookASCP on InstagramASCP on TwitterConnect with Dr. SanfordDr. Sanford on TwitterDr. Sanford at VCUConnect with Dr. MessiasDr. Messias on TwitterDr. Messias at Washington University  Connect with Ms. ChannerMs. Channer on LinkedIn Connect with Dr. Mulder & Ms. SwailsDr. Mulder on Twitter Ms. Swails on Twitter Resources Dr. Emma Sadler MossInside the Lab in the ASCP Store 

Hi friends, this is Dr. Michael Williams and welcome back to another episode of the diversify in path podcast.  This podcast explores how investing in diversity can lead to a high return of investment in pathology and laboratory medicine by learning from the knowledge and experiences of diverse voices within our field.My next guest is Dr. Chinelo OnyenekwuDr. Chinelo Onyenekwu is a graduate of medicine from the University of Lagos, Nigeria.  She has served as a medical officer with the Nigerian Navy and a resident at the Lagos university Teaching Hospital currently holding double board certification in Chemical Pathology from the National Postgraduate Medical College of Nigeria and the West African College of Physicians.Over 14 years, she has successfully built a career in laboratory medicine, quality management, clinical and operational research. Dr. Onyenekwu has held academic and administrative roles in tertiary academic and health institutions in Nigeria and South Africa. She currently is a third-year pathology resident at the Medical College of Wisconsin (MCW) where she is actively involved in various research works. She is a clinical pathology enthusiast with interests in laboratory quality management and quality improvement. Outside of residency training, she serves as a co-editor of the MCW Pathology Twitter page. She loves to travel, try out new recipes and is actively involved in mentoring medical students and graduates applying for pathology residency. Dr. Onyenekwu is a future Transfusion Medicine fellow at the Johns Hopkins Hospital.

Welcome to season 2 of Sign Out Sessions! In this episode we talk with Dr. Sarah Barnhard, the current Transfusion Medicine director at UC Davis Medical Center. We discuss her journey from growing up in the midwest, to moving to New York before eventually joining UC Davis. Please rate, comment and subscribe. We'd greatly appreciate it! If you have any questions or want to reach out to us directly, our email is sosucdmc@gmail.com.

Are you familiar with the concept of oxygen debt or oxygen deficit? What constitutes a “dose” of shock? What systolic BP constitutes hypotension on the battlefield? Where did the concept of permissive hypotension come from? Is it still valid? How long can fresh whole blood last? Blood Transfusions were a huge topic at this year's meeting in Charlotte with no less than 3 major speakers giving multiple talks on the subject. This talk was recorded during the Prolonged Field Care Pre-Conference Lab during the Special Operations Medicine and Scientific Assembly (SOMSA). Dr. Geir Strandenes is a founding member of the THOR (Tactical Hemostasis, Oxygenation, and Resuscitation) Group, the Senior Medical Officer of the Norwegian Naval Special Operations, and a Researcher in the Department of Immunology and Transfusion Medicine at Haukeland University Hospital in Bergen, Norway. He has worked hand-in-hand with the U.S. Army Institute of Surgical Research and the US Armed Forces Blood Program. You can read more about his research and other articles at www.RDCR.org. Our PFC working group has always gone to the THOR network with any blood questions that we have, as they usually have an answer or best practice already established. I have included a link to the THOR/RDCR.org publication page below along with other notable publications which he helped to author such as the recently published JTS ISR Clinical Practice Guideline on Damage Control Resuscitation and the Frequently Asked Questions we sent to Geir and the THOR network over the last couple years. www.prolongedfieldcare.org

Dr. Jennifer Andrews is an Associate Professor of Pediatrics and Pathology at the Vanderbilt University School of Medicine. Dr. Andrews received her MD at the University of South Florida and completed her residency in pediatrics at the University of North Carolina. She completed her fellowship in pediatric hematology at Emory University and another fellowship in transfusion medicine at Stanford University. She was on staff at Stanford until joining Vanderbilt in 2018. Dr. Andrews specializes in the hemolytic disease of the fetus and newborn. Dr. Andrews sees patients as a pediatric hematologist and runs the blood bank at Vanderbilt University Medical Center. Tune in to learn about common blood disorders, hemolytic disease of the newborn, and the ins and outs of transfusion medicine.

Deepali Patil nee' Patravali has navigated her decisions keeping the big picture of life and fulfillment in mind. We all knew she was brilliant – but now I realized she was wise. Not only a Transfusion Medicine specialist, she is a yoga teacher, a Meditation teacher, a Happiness teacher and a Craniosacral specialist. All in all a healer. Listen on as she introduces herself over the course of the next 45 minutes. It was fantastic meeting her again. She lives in Belgaum with her soulmate Rahul Patil daughter Isha and son Shaurya. --- Send in a voice message: https://podcasters.spotify.com/pod/show/epistle91/message

Tiffany Channer, MPH, MLS(ASCP)CM  the current Chair of the ASCP's Council of Lab Professionals gives insight into ways you can use your association with professional organizations to advocate for the profession as well as gain leadership skills to enhance your career. Tiffany is an Assistant Administrative Laboratory Director and Quality Manager for a community hospital in White Plains NY. She has worked various areas of the laboratory with most of her experience being in Transfusion Medicine. She has gained experience from several health systems in both New York and Florida.A few leadership nuggets that Tiffany shared:-Get involved being a career ambassador and presenting to high school students-When you climb the corporate ladder never forget that you started off as a tech- You don't have to know it all, that's why you build a network of people you can call on -Be an advocate for yourselfListen to the entire show for more leadership gold! Don't forget to subscribe to the show, leave a comment, and share with a fellow medical laboratory professional!

Written by Dr. Grace Zhang (internal medicine resident)Reviewed by  Dr. Graeme Quest (Hematopathologist)Dr. Siddhartha Srivastava (General Internist)Infographic by: Lucy Lan (Medical Student)In this episode we go over the indications and typical uses of blood products: including red blood cells, platelets, fibrinogen, PCC and albumin. 

Written by Dr. Grace Zhang (internal medicine resident)Reviewed by  Dr. Graeme Quest (Hematopathologist)Dr. Siddhartha Srivastava (General Internist)Infographic by: Lucy Lan (Medical Student)Part 2 of our blood transfusion series goes into acute and delayed transfusion reactions. From fever, to TACO to graft vs. host, we cover it all. Most importantly, ABC's, stop the transfusion, call for help, and keep the blood products and tubing to send to the blood bank!